Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PQ912 in MCI and Mild Dementia Due to Alzheimer's Disease
NCT04498650Phase 2Completed
- Sponsor
- Vivoryon Therapeutics N.V.
- Start
- Jul 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of varoglutamstat in Alzheimer's disease (AD), sponsored by Vivoryon Therapeutics N.V.. Started Jul 2020; status: completed.
02
Drugs
varoglutamstat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04498650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498650.